Anti-VEGF therapy appeared particularly effective in stage 4 disease, whereas vitrectomy showed a trend toward better outcomes in stage 5.
← all excerpts
Outcomes of anti-VEGF therapy compared with conventional interventions in diabetic retinopathy management.
1
—
—